News | November 10, 2023
GSK registers 5% revenue growth in Q2 FY24
General Medicine grows 5% and Vaccines 10% led by Shingrix
General Medicine grows 5% and Vaccines 10% led by Shingrix
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
The collaboration brings a seamless digital experience to more formulators worldwide
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
PhytoSquene now available for clinical and commercial use
This product will be manufactured at Lupin’s Pithampur facility in India
This product will be manufactured at Lupin's Nagpur facility in India
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
The European Commission approved the use of Carbopol as an additive for liquid and solid food supplements in the EU
Subscribe To Our Newsletter & Stay Updated
